Addition of Bortezomib (velcade) to Aml Induction Chemotherapy is Well Tolerated and Results in A High Complete Remission RateEC Attar,DJ De Angelo,A Sirulnik,M Wadleigh,KK Ballen,KB Miller,I Galinsky,D Neuberg,E Trehu,D Schenkein,RM Stone,PC AmreinBLOOD(2005)引用 18|浏览21暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要